Drug Trial Radar · NCT03695432
Probiotic and Influenza Vaccination to Reducing Influenza-like Illness Incident in Elderly
Last checked: Nov 19, 2026Latest source record: Oct 5, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
910
Actual
Start
Oct 2014
Primary completion
Apr 2015
Study completion Jul 2016
Sponsor
- Lead sponsor
- Universitas IndonesiaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 4, 2018
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Single (outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 60 years, up to 90 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
To asses the effect of the probiotic and influenza vaccination alone and combination on enhancing immune response to influenza-like illness (ILI) and reducing ILI incidence in the elderly
Conditions
- Influenza-like Illness
Interventions
FlubioBiological
Flubio (A/California/7/2009, A/Texas/50/2012 and B/Massachusetts/2/2012) Vaccine 0,5 ml for every subjects The vaccine will be given intramuscularly
LacidofilDietary supplement
Lacidofil (Lactobacillus acidophilus Rossel-52 and Lactobacillus rhamnosus Rosell-11 with maltodextrin 211 mg, magnesium stearat 8 mg and ascorbic acid 1 mg) antibiotic The antibiotic will be given 2 times each day for 6 months
Placebo VaccineOther
Nacl 0,9% 0,5 ml The placebo vaccine will be given intramuscularly
Placebo probioticOther
Capsul
Primary outcomes
What the sponsor says the trial is designed to measure.
- The precentage enhancement of the immune response to flubio vaccine and probiotic compared to plasebo 6 months after vaccinationTime frame: 6 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Integrated Health Post, at Pulo Gadung District
Jakarta, DKI Jakarta, Indonesia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.